BCMA-CD19 CAR-T

BCMA-CD19 chimeric antigen receptor T-cell therapy · iCell Gene Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCMA-CD19 CAR-T, covering 2025-09-16 to 2025-09-16. Get the full timeline:

Most recent: Clinical Trial Update: BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma [Phase 1]